The upgrade IMPACT

A significant upgrade at the proton accelerator facility

The proton accelerator HIPA has been in operation since 1974 and has been expanded repeatedly since then. It is known worldwide for generating especially large numbers of protons per second in a continuous stream for research. To enhance internationally top-level research, a strategically significant upgrade is now underway for HIPA. It bears the name IMPACT: Isotope and Muon Production with Advanced Cyclotron and Target Technologies. As a joint project of PSI, the University of Zurich, and the University Hospital of Zurich, IMPACT is to be implemented in the Swiss research funding period that begins in 2025.

Impact
With the HIMB upgrade producing 100 times more muons than today, scientists will be able to probe extremely rare processes with far greater precision – the kind of measurements that require vast numbers of particles to detect the faintest possible signals.

HIMB: More muons for outstanding experiments

HIMB stands for High-Intensity Muon Beams. This part of IMPACT is an upgrade of the muon facility. 

With the new TATTOOS facility, PSI will be able to both increase the range of medical radionuclides available for research and increase the quantity produced.

TATTOOS

TATTOOS stands for Targeted Alpha Tumour Therapy and Other Oncological Solutions. With TATTOOS, PSI wants to significantly expand its current production of radionuclides – medicinal substances that can be used to treat cancer. At PSI, the Center for Radiopharmaceutical Sciences specialises in research on these active agents.

Terbium
•Health Innovation
•4 min

Radiopharmacy: past, present and future

Radiopharmacy
Medical Science
TATTOOS
IMPACT

Radiopharmaceuticals allow some types of cancer to be targeted with tailor-made therapies. The current state of the art was preceded by decades of intensive research – and the future promises even better treatment options.

More news to the project